Neurocrine Biosciences (NBIX) Change in Taxes (2024 - 2026)

Neurocrine Biosciences' Change in Taxes history runs 3 years deep, the most recent figure standing at $119.8 million for Q1 2026.

• Quarterly Change in Taxes rose 677.92% year-over-year to $119.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $225.8 million (changed N/A YoY) and the FY2025 annual result came in at -$18.8 million, down 137.38% from the prior year.
• Change in Taxes was $119.8 million for Q1 2026 at Neurocrine Biosciences, up from $35.5 million in the prior quarter.
• Across five years, Change in Taxes topped out at $119.8 million in Q1 2026 and bottomed at $15.4 million in Q1 2025.
• A 3-year average of $56.4 million and a median of $45.3 million in 2024 frame the typical range for Change in Taxes.
• Annual changes were most pronounced in 2025 — Change in Taxes tumbled 35.57% — and 2026, when it surged 677.92%.
• Neurocrine Biosciences' Change in Taxes stood at $55.1 million in 2024, then tumbled by 35.57% to $35.5 million in 2025, then jumped by 237.46% to $119.8 million in 2026.
• Business Quant data shows NBIX's Change in Taxes at $119.8 million in Q1 2026, $35.5 million in Q4 2025, and $15.4 million in Q1 2025.